Grant Proposal On Outcomes Of Fibrinolytic Therapy Versus PCI Grant Proposal

Length: 4 pages Sources: 1+ Subject: Medicine Type: Grant Proposal Paper: #51996936 Related Topics: Proposal, Therapy, Crisis Intervention, Pharmacology
Excerpt from Grant Proposal :

Grant Proposal on Outcomes of fibrinolytic therapy vs. PCI

Evidence-based medicine requires foundational inquiry and support. Heart disease, thrombolytic disease, pulmonary embolism, deep vein thrombosis, stroke and preliminary stroke occurrences and myocardial infarction are fundamentally significant challenges in medicine and community. Treatment of varied presentations of thrombolytic crisis deserve significant research inquiry and time given the severity of the potential outcomes and the numbers of individuals who seek treatment daily for heart disease and acute cardiac and venous crisis and the number of people who have both positive and negative medical and life outcomes during all levels of intervention. The various treatment options for acute and often potentially deadly cardiac crisis are often well tested and well established, yet they also require constant vigilance on the part of clinical researchers and practitioners to develop appropriate and best practices for best possible outcomes for patients. It is well established that outcomes of fibrinolytic therapy vs. primary percutaneous coronary intervention (PCI) vary with the most important functions of PCI being the immediacy of its performance, hence the door-balloon initiative contending that PCI be performed within 90 minutes of entrance for acute ST segment elevation myocardial infarction (STEMI) yet further research must be conducted to reiterate the importance of fibrinolytic therapy in concordance with PCI and also as an alternative when the door-to-balloon window has been bridged over time, be it from time of event beginning or time of treatment...

...

PCI treatment has been and will likely continue to be a well received and effective rapid treatment option yet it should not exclude fibrinolytic therapy as another viable option in a case by case scenario especially in cases where STEMI is identified after the door-to-balloon window has expired. This work will describe an historical review of acute treatment outcomes for those who have received exclusive fibrinolytic therapy or PCI.

Statement of Need

The work will reiterate the need for further and appropriate outcomes-based research and evidence based intervention in STEMI and other acute cardiac presentations. The budget for the project will be 100,000 which will include minimal payment to the research team, time allocated for development of case work and minimal payment to physicians and participants, associated with the improvement of facility options and appropriations for acute cardiac treatment.

Evidence-based medicine requires foundational inquiry and support. Heart disease, thrombolytic disease, pulmonary embolism, deep vein thrombosis, stroke and preliminary stroke occurrences and myocardial infarction are fundamentally significant challenges in medicine and community. Treatment of varied presentations of thrombolytic crisis deserve significant research inquiry and time given the severity of the potential outcomes and the numbers of individuals who seek treatment daily for heart disease and acute cardiac and venous crisis and the number of people who have both positive and negative medical and life outcomes during all levels of intervention. The various treatment options for acute and often potentially deadly cardiac crisis are often well tested and well established, yet they also require constant vigilance on the part of clinical researchers and practitioners to develop appropriate and best practices for best possible outcomes for patients. It is well established that outcomes of fibrinolytic therapy vs. primary percutaneous coronary intervention (PCI) vary with the most important functions of PCI being the immediacy of its performance, hence the door-balloon initiative contending that PCI be performed within 90 minutes of entrance for acute ST segment elevation myocardial infarction (STEMI) identification. Further research must be conducted to reiterate the importance of fibrinolytic therapy in concordance with PCI and also as an alternative when the door-to-balloon window has been bridged over time, be it from time.

Project Description

Fibrinolytic therapy was the most logical and appropriate treatment for STEMI as well a other arterial and vascular crisis intervention prior to the availability of PCI treatment. Since that time Fibrinolytic therapy, despite its various advancements has been set aside as a viable first response to cardiac crisis. This is clearly a logical step in the…

Sources Used in Documents:

Resources

Erdim, R., Erciyes, D., Gormez, S., Karabay, K., Catakoglu, A., Aytekin, V., & ... Gulbaran, M. (2010). Comparison of intracoronary vs. intravenous administration of tirofiban in primary percutaneous coronary intervention. Anatolian Journal Of Cardiology / Anadolu Kardiyoloji Dergisi, 10(4), 340-345. doi:10.5152/akd.2010.093

Hunter, S. (2010). Clinical: Journals Watch - MI, hypertension and diabetes. GP: General Practitioner, 26.

Knight, C., & Timmis, A.D. (2011). Almanac 2011: acute coronary syndromes. Kardio List, 6(12), 367-382.

Li, Y., Rha, S., Chen, K., Jin, Z., Minami, Y., Wang, L., & ... Jeong, M. (2010). Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: Lessons from the Korea Acute Myocardial Infarction Registry. Clinical & Experimental Pharmacology & Physiology, 37(5/6), 581-586. doi:10.1111/j.1440-1681.2010.05363.x


Cite this Document:

"Grant Proposal On Outcomes Of Fibrinolytic Therapy Versus PCI" (2012, April 14) Retrieved July 4, 2022, from
https://www.paperdue.com/essay/grant-proposal-on-outcomes-of-fibrinolytic-112848

"Grant Proposal On Outcomes Of Fibrinolytic Therapy Versus PCI" 14 April 2012. Web.4 July. 2022. <
https://www.paperdue.com/essay/grant-proposal-on-outcomes-of-fibrinolytic-112848>

"Grant Proposal On Outcomes Of Fibrinolytic Therapy Versus PCI", 14 April 2012, Accessed.4 July. 2022,
https://www.paperdue.com/essay/grant-proposal-on-outcomes-of-fibrinolytic-112848

Related Documents
Myocardial Infarction According to the Centers for
Words: 744 Length: 2 Pages Topic: Disease Paper #: 33223735

Myocardial Infarction According to the Centers for Disease Control and Prevention (CDC, 2006), each year approximately 1.2 million Americans suffer from myocardial infarction (heart attack) each year. 40% of these people who a have heart attack will die from it. This equates to a person having a heart attack every 34 seconds, and a person dying from a heart attack every minute. Heart disease is the leading cause of death in

Myocardial Infarction
Words: 870 Length: 3 Pages Topic: Anatomy Paper #: 59692005

MI Case Study: Myocardial Infarction At 10:05 A.M., the blockage that had been silently growing in Paul Parker's left coronary artery made its sinister presence known. The 54-year-old accounting executive had arrived with his family at the Denver zoo feeling fine, but suddenly a dull ache started in the center of his chest and he became nauseated. At first he brushed it off as the aftereffects of a company dinner the night

Myocardial Infarction Risk for Women with Breast Cancer
Words: 1434 Length: 5 Pages Topic: Nursing Paper #: 38377819

Myocardial Infarction Risk for Women with Breast Cancer: Annotated Bibliography Abdel-Qadir, H., Amir, E., Fischer, H. D., Fu, L., Austin, P. C., Harvey, P. J., ... & Anderson, G. M. (2016). The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer. European Journal of Cancer, 68, 11-21. The rationale for this study was that a gap in the literature existed with respect to the possibility

Acute Myocardial Infarction Pathophysiological Process Template Disease:...
Words: 1549 Length: 5 Pages Topic: Anatomy Paper #: 71859331

Acute Myocardial Infarction PATHOPHYSIOLOGICAL PROCESS TEMPLATE DISEASE: Acute Myocardial Infarction is a common disease with very grave consequences in morbidity, mortality and cost to the society (Boersma et.al, 2003) It has become the leading cause of death in the developed world. It has been estimated that about 450,000 people die from coronary disease per year in the United States. Myocardial infarction primarily occurs when the blood supply to the heart is compromised. Just like

Health Care Services for Myocardial Infarction: Myocardial
Words: 2008 Length: 6 Pages Topic: Healthcare Paper #: 93325634

Health Care Services for Myocardial Infarction: Myocardial Infarction (MI) is commonly known as Acute Myocardial Infarction (AMI) is a heart attack disease in which blood supply to a part of the heart is interrupted resulting in ultimate irreversible damage and cell death in that part of the heart (Khan, 2010). As one of cardiovascular diseases, myocardial infarction can be regarded as one of the leading causes of death for men

Aspirin for Acute Myocardial Infarction
Words: 13907 Length: 51 Pages Topic: Disease Paper #: 65369456

5% while 70.5% took Aspirin within six hours after reaching hospital and 76.5% of patients admitted in the NICVD were receiving Aspirin therapy." (Jaiwa, 2006, p.1) Jaiwa reports a more recent study that states findings that out of 52 patients with chest pain only 13 patients or 25% of the 52 received aspirin. The stated reason for not giving aspirin to the other 39 patients included that "chest pain was not